Cluster | Cluster address (hg19) | Width | N | Ng | Tr | Tr-max | Tr-Ext | Ret | GWAS traits | Top GSEA categories |
---|---|---|---|---|---|---|---|---|---|---|
1 | chr1:118158079-118174222 | 16,144 | 8 | 0 | 10 | 8 | 0 | 1 | Â | Platelet |
2 | chr1:158810312-158827365 | 17,054 | 2 | 0 | 7 | 7 | 0 | 0 | Â | Â |
3 | chr1:205040943-205268803 | 227,861 | 114 | 4 | 14 | 11 | 0 | 5 | Mean platelet volume, Platelet counts | . |
4 | chr1:248038210-248047688 | 9479 | 4 | 3 | 15 | 12 | 2 | 1 | Mean corpuscular volume, Platelet counts, Red blood cell traits | . |
5 | chr2:8740722-8766192 | 25,471 | 23 | 0 | 24 | 21 | 0 | 2 | Â | Catabolic process |
6 | chr2:60708597-60727629 | 19,033 | 19 | 24 | 18 | 15 | 7 | 1 | Beta thalassemia/hemoglobin E disease, F-cell distribution, Fetal hemoglobin levels, Sickle cell anemia (hemolysis) | . |
7 | chr2:85715315-85809703 | 94,389 | 51 | 1 | 15 | 12 | 0 | 0 | Prostate cancer | Neutrophil |
8 | chr2:160326049-160674656 | 348,608 | 381 | 0 | 26 | 21 | 1 | 0 | Â | Liver cancer progression, fibroblast cell response, Neutrophil, MicroRNA targets |
9 | chr3:49734040-50308718 | 574,679 | 435 | 2 | 38 | 34 | 0 | 0 | HDL cholesterol, Menarche (age at onset) | Dendritic cells response |
10 | chr3:56829892-56953738 | 123,847 | 185 | 9 | 128 | 127 | 85 | 3 | Mean platelet volume, Platelet counts | Platelet, hemostasis, Neutrophil |
11 | chr3:100905910-101550022 | 644,113 | 544 | 0 | 37 | 33 | 17 | 0 | Â | Genes in band chr19q13, transcription pathway |
12 | chr3:121350573-121471367 | 120,795 | 35 | 0 | 8 | 8 | 0 | 1 | Â | Â |
13 | chr3:176869498-176928657 | 59,160 | 104 | 0 | 9 | 8 | 0 | 0 | Â | Â |
14 | chr4:103391275-103540762 | 149,488 | 77 | 1 | 7 | 7 | 0 | 0 | Ulcerative colitis | . |
15 | chr5:148198999-148213506 | 14,508 | 42 | 0 | 35 | 32 | 0 | 0 | Â | Neutrophil, kidney glomeruli cell response |
16 | chr5:173287763-173363889 | 76,127 | 9 | 2 | 14 | 13 | 0 | 5 | Crohn’s disease, Waist–hip ratio | . |
17 | chr6:135402339-135459837 | 57,499 | 27 | 24 | 26 | 23 | 7 | 6 | Beta thalassemia/hemoglobin E disease, Cholesterol, total, F-cell distribution, HbA2 levels, Hematocrit, Hematological parameters, Hematology traits, Hodgkin's lymphoma, Mean corpuscular hemoglobin, Mean corpuscular hemoglobin concentration, Mean corpuscular volume, Mean platelet volume, Other erythrocyte phenotypes, Platelet counts, Red blood cell traits, White blood cell count, White blood cell types | CD71+, MicroRNA targets |
18 | chr6:139764573-139844429 | 79,857 | 48 | 9 | 73 | 50 | 13 | 17 | Adiponectin levels, HDL cholesterol, Mean corpuscular hemoglobin, Mean corpuscular volume | CD71+, Neutrophil, MicroRNA targets |
19 | chr6:144190433-144674657 | 484,225 | 172 | 0 | 43 | 34 | 1 | 0 | Â | Neutrophil, MicroRNA targets |
20 | chr6:159498130-159539213 | 41,084 | 14 | 0 | 10 | 9 | 0 | 0 | Â | Hematopoetic cells response, Neutrophil |
21 | chr6:167362976-167403400 | 40,425 | 6 | 3 | 7 | 6 | 0 | 0 | Crohn’s disease, Graves’ disease, Inflammatory bowel disease | Hematopoetic cells response |
22 | chr7:28716154-28874761 | 158,608 | 11 | 0 | 19 | 17 | 0 | 0 | Â | Neutrophil |
23 | chr7:33035342-33096644 | 61,303 | 5 | 0 | 12 | 11 | 0 | 5 | Â | . |
24a | chr7:50366637-50417632 | 50,996 | 3 | 0 | 40 | 40 | 2 | 2 | Â | Dendritic cell vs monocyte response, Neutrophil |
25a | chr7:50367656-50671350 | 303,695 | 292 | 6 | 93 | 82 | 19 | 17 | Acute lymphoblastic leukemia (B-cell precursor), Acute lymphoblastic leukemia (childhood), Mean corpuscular volume, Red blood cell traits | CD71+, MicroRNA targets |
26 | chr7:106367604-106373718 | 6115 | 8 | 6 | 6 | 6 | 0 | 1 | Mean platelet volume | . |
27 | chr8:61595671-61658073 | 62,403 | 10 | 0 | 6 | 6 | 0 | 0 | Â | Â |
28 | chr9:99087217-99192919 | 105,703 | 12 | 1 | 7 | 7 | 0 | 0 | Height | Bone marrow progenitor cells response |
29 | chr9:126971204-127002414 | 31,211 | 20 | 0 | 20 | 16 | 1 | 0 | Â | Kidney glomeruli cells response, Neutrophil, MicroRNA targets |
30 | chr9:131561110-131645659 | 84,550 | 58 | 0 | 10 | 10 | 0 | 0 | Â | Hematopoetic cells response, Neutrophil |
31 | chr9:140655551-140696524 | 40,974 | 14 | 0 | 7 | 6 | 0 | 0 | Â | . |
32 | chr10:37976990-38692432 | 715,443 | 221 | 0 | 9 | 7 | 0 | 0 | Â | . |
33 | chr10:65016174-65104500 | 88,327 | 18 | 6 | 6 | 6 | 1 | 0 | Mean platelet volume, Platelet counts, Triglycerides | Platelet |
34 | chr11:212408-247028 | 34,621 | 15 | 1 | 6 | 6 | 1 | 0 | Platelet counts | Coagulation, Platelet |
35 | chr11:108021205-108367453 | 346,249 | 248 | 3 | 8 | 7 | 3 | 0 | Melanoma, Response to metformin, Response to metformin in type 2 diabetes (glycemic) | Neutrophil |
36 | chr12:54584330-54584330 | 1 | 1 | 0 | 7 | 7 | 0 | 0 | Â | Genes with certain promoter motif |
37a | chr12:54622328-54733728 | 111,401 | 6 | 2 | 7 | 6 | 0 | 0 | Mean platelet volume, Platelet counts | Genes in band chr14q24 |
38a | chr12:54668471-54761931 | 93,461 | 27 | 3 | 29 | 14 | 2 | 0 | Mean platelet volume, Platelet counts | Platelet |
39 | chr12:111833788-112896839 | 1,063,052 | 25 | 35 | 17 | 15 | 7 | 0 | Beta-2 microglobulin plasma levels, Blood pressure, Celiac disease, Celiac disease and Rheumatoid arthritis, Cholesterol, total, Chronic kidney disease, Coronary artery disease or ischemic stroke, Coronary artery disease or large artery stroke, Coronary heart disease, Diastolic blood pressure, Eosinophil counts, Hematocrit, Hematological parameters, Hemoglobin, Hypothyroidism, Ischemic stroke, LDL cholesterol, Mean platelet volume, Platelet counts, Red blood cell traits, Retinal vascular caliber, Rheumatoid arthritis, Systolic blood pressure, Tetralogy of Fallot, Type 1 diabetes, Type 1 diabetes autoantibodies, Upper aerodigestive tract cancers, Urate levels, Vitiligo | Interferon signaling, Cytokine signaling, Immune system |
40 | chr12:122216910-122366612 | 149,703 | 3 | 5 | 12 | 12 | 0 | 0 | Mean platelet volume, Platelet counts | Platelet, Neutrophil |
41 | chr12:129277164-129305613 | 28,450 | 56 | 1 | 17 | 16 | 0 | 0 | Systemic lupus erythematosus | . |
42 | chr14:24888248-24904602 | 16,355 | 19 | 0 | 13 | 13 | 0 | 3 | Â | Â |
43 | chr14:35372518-35847784 | 475,267 | 360 | 2 | 18 | 17 | 1 | 0 | Psoriasis | Pancreatic cancer cell response, Neutrophil, MicroRNA targets |
44 | chr16:57045349-57070617 | 25,269 | 31 | 0 | 11 | 11 | 1 | 0 | Â | IFNG responsive |
45 | chr16:87749634-87770469 | 20,836 | 6 | 0 | 9 | 9 | 0 | 0 | Â | Â |
46a | chr16:89802396-89992238 | 189,843 | 4 | 14 | 11 | 8 | 0 | 0 | Freckling, Hair color, Homocysteine levels, Vitiligo | . |
47a | chr16:89919081-89993206 | 74,126 | 102 | 9 | 9 | 8 | 0 | 0 | Basal cell carcinoma, Blond vs. brown hair color, Freckles, Hair color, Non-melanoma skin cancer, Red vs non-red hair color, Skin sensitivity to sun, Sunburns, Tanning | . |
48 | chr17:15899871-16239832 | 339,962 | 137 | 0 | 9 | 7 | 1 | 0 | Â | Beta catenin signaling, Neutrophil |
49 | chr17:26887271-27323322 | 436,052 | 252 | 0 | 44 | 41 | 0 | 11 | Â | PBMC response, CD71+, Neutrophil, MicroRNA targets |
50 | chr17:33763678-33819401 | 55,724 | 22 | 0 | 23 | 21 | 0 | 1 | Â | PBMC response, MicroRNA targets |
51a | chr17:33823254-34067892 | 244,639 | 360 | 2 | 141 | 95 | 8 | 26 | Platelet counts, Mean platelet volume | PBMC response, CD71+, Platelet, MicroRNA targets |
52a | chr17:33885467-33899846 | 14,380 | 3 | 2 | 11 | 9 | 0 | 0 | Platelet counts, Mean platelet volume | Platelet, PBMC vs. Tcells |
53 | chr18:43716475-43856354 | 139,880 | 121 | 0 | 10 | 9 | 0 | 2 | Â | Â |
54 | chr20:4139757-4188267 | 48,511 | 70 | 0 | 40 | 33 | 0 | 8 | Â | PBMC response, CD71+ |
55 | chr20:62529985-62565833 | 35,849 | 54 | 0 | 9 | 9 | 0 | 1 | Â | Glioma cell response |
56 | chr21:44471469-44492843 | 21,375 | 7 | 3 | 6 | 6 | 1 | 0 | Blood trace element (Se levels), Homocysteine levels, Obesity-related traits | . |
57 | chr22:32311619-32326021 | 14,403 | 17 | 0 | 8 | 8 | 0 | 0 | Â | Hematopoetic cell response, Neutrophil |
58 | chr22:49967868-50069539 | 101,672 | 128 | 0 | 18 | 16 | 0 | 0 | Â | Â |
59 | chrX:40802981-40847852 | 44,872 | 52 | 0 | 31 | 30 | 0 | 7 | Â | CD71+ |